STOCK TITAN

The Oncology Institute Names Jeremy Castle as Chief Operations Officer

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
The Oncology Institute, Inc. appoints Jeremy Castle as Chief Operations Officer.
Positive
  • Jeremy Castle brings significant oncology operations experience and expertise in value-based care to TOI, which will greatly benefit the company's growth.
Negative
  • None.

CERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company.

Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving growth and profitability for multi-state physician groups. He has had other senior leadership positions, including Mr. Castle having previously served as the Chief Operating Officer for United Urology Group and Executive Director for The US Oncology Network.

“We are thrilled to welcome Jeremy to TOI as our Chief Operations Officer,” shared Chief Executive Officer, Dr. Daniel Virnich. “He brings significant oncology operations experience, as well as deep experience with value-based care, and I am confident that his expertise in Oncology will greatly benefit TOI as we seek to rapidly accelerate our growth.”

“TOI is entering an exciting chapter in its history, and I feel energized to join this team of progressive and passionate leaders and clinicians dedicated to changing oncology for the better,” said Castle. “As Chief Operations Officer, I will have the opportunity to serve TOI’s patients, teammates, community, and shareholders. I look forward to contributing to the company’s continued success.”

About TOI

Founded in 2007, The Oncology Institute, Inc. (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 800 teammates in over 65 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com 


FAQ

Who is the new Chief Operations Officer of The Oncology Institute, Inc.?

Jeremy Castle.

What is Jeremy Castle's background?

He has over 15 years of oncology industry experience and a track record of driving growth and profitability for multi-state physician groups.

What role will Jeremy Castle play in TOI?

He will lead enterprise field and central operations, pharmacy, real estate, and practice integration.

What is the CEO's opinion about Jeremy Castle's appointment?

The CEO, Dr. Daniel Virnich, is confident that Jeremy Castle's expertise in oncology will greatly benefit TOI's growth.

What does Jeremy Castle think about joining TOI?

He feels energized to join the team and looks forward to contributing to the company's success.

What is TOI's goal?

TOI aims to rapidly accelerate its growth and change oncology for the better.

The Oncology Institute, Inc.

NASDAQ:TOI

TOI Rankings

TOI Latest News

TOI Stock Data

21.14M
75.49M
19.56%
45.35%
0.33%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
CERRITOS